Efficacy and Safety of AK002 in Adult Patients with Active Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis: Primary Results from a Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial (ENIGMA Study)

Evan S Dellon  ¹     Kathryn Peterson  ²     Joseph A. Murray  ³     Gary W. Falk  ⁴     Nirmala Gonsalves  ⁵     Mirna Chehade     John Leung     Robert Genta     Marc E. Rothenberg     Paneez Khoury     Adam Bledsoe     Camilla Shaw     Henrik Rasmussen     BHUPINDER SINGH     Alan Chang     Amol Kamboj     Ikuo Hirano    
¹ University of North Carolina at Chapel Hill,Chapel Hill,United States
² University of Utah School of Medicine,Salt Lake City,United States
³ Mayo Clinic, Rochester,Rochester,United States
⁴ University of Pennsylvania Perelman School of Medicine,Pennsylvania,United States
⁵ Northwestern University School of Medicine,Chicago,United States

Session
Late breaking abstracts: From eosinophilic oesophagitis to novel obesity therapies

Conference
UEG Week 2019

Citation
United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019